Vaxchora has been available in the US since 2016, when it was the first vaccine to be approved by the FDA to protect against diarrhoeal disease caused by Vibrio cholerae serogroup O1, the globally ...
The global cholera vaccine market is driven by several factors, including the rising frequency of cholera outbreaks, especially in regions with poor sanitation and limited access to clean water.
In such places, cholera infects between one and four million people every year, per the World Health Organization, and contributes to some 21,000 to 143,000 deaths annually. Here's what cholera is, ...
The Qwen team said that QwQ-Max-Preview – built on the most advanced model of the series, the Qwen 2.5-Max introduced last month – displayed stronger and more versatile reasoning and problem ...
With a modest size of just 1.5 billion parameters, DeepScaler has achieved remarkable results, surpassing OpenAI’s o1-Preview in general math benchmarks. This accomplishment highlights the ...
We’re now into the third year of the AI boom, and industry leaders are showing no signs of slowing down, pushing out newer and (presumably) more capable models on a regular basis. ChatGPT, of ...
Microsoft is taking an aggressive step towards lowering the price of top-tier AI reasoning, giving Copilot users free, unlimited access to OpenAI’s o1 model directly within Copilot’s new ...
Probiotics are emerging as a promising adjunctive therapy, offering significant potential in addressing antibiotic-resistant Vibrio cholerae strains. Incorporating probiotics into existing management ...
OpenAI’s o3-Mini Shows Superior Accuracy Than o1-Mini Without ‘Thinking’ Longer: Harvard Study
The study explores whether the longer chain of thoughts leads to more accurate responses. The authors compared the results of OpenAI’s o1-mini and the o3-mini medium, one of the company’s newer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results